STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major CLL study tests three drug combos in seniors
Disease control OngoingThis study looked at 547 older adults (65+) with untreated chronic lymphocytic leukemia (CLL). It compared three treatments: bendamustine plus rituximab, ibrutinib plus rituximab, or ibrutinib alone. The goal was to see which combination best delays cancer growth. Participants re…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy aims to boost immunity against early blood cancer
Disease control OngoingThis study tests whether the drug lenalidomide, combined with a vaccine, can help the immune system fight early-stage chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in people with high-risk genetic features. About 49 participants will receive the treatment…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New CMV strategy aims to protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or disorders. About 153 participants are involved, and the goal is to see if changing when and how anti-CMV drugs are…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC